TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio-Rad Laboratories AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
96,402
|
102,885
|
87,094 |
| Financial expenses |
0
|
0
|
498 |
| Earnings before taxes |
2,736
|
4,423
|
16,204 |
| EBITDA |
2,666
|
4,671
|
5,396 |
| Total assets |
87,091
|
103,905
|
81,081 |
| Current assets |
41,084
|
62,469
|
42,113 |
| Current liabilities |
31,562
|
48,760
|
33,502 |
| Equity capital |
55,017
|
52,002
|
45,342 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
26
|
25
|
25 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.2%
|
50.0%
|
55.9% |
| Turnover per employee |
3,708
|
4,115
|
3,484 |
| Profit as a percentage of turnover |
2.8%
|
4.3%
|
18.6% |
| Return on assets (ROA) |
3.1%
|
4.3%
|
20.6% |
| Current ratio |
130.2%
|
128.1%
|
125.7% |
| Return on equity (ROE) |
5.0%
|
8.5%
|
35.7% |
| Change turnover |
-8,338
|
9,611
|
-11,536 |
| Change turnover % |
-8%
|
10%
|
-12% |
| Chg. No. of employees |
1
|
0
|
-8 |
| Chg. No. of employees % |
4%
|
0%
|
-24% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.